Viking Therapeutics, Inc. aces hurdles for obesity drug VK2735 vs. Zepbound/Wegovy—tolerability, weak differentiation, and ...
Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts ...
SoFi stock rises 4% as Q4 revenue hits record $1 billion, beating estimates. Company adds 1M members and forecasts strong ...
Cynata Therapeutics, Racura Oncology and Dimerix are among ASX health companies reporting milestones reached in quarterly ...
Nvidia's third-quarter financial results on Wednesday surpassed analyst expectations, signaling that demand for its artificial intelligence chips remains robust amid investor concerns about an AI ...
Matthew Ricketson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
Objective: We sought to evaluate the relationship between biosimilar introduction and the prices and expenditures of biologics in high-income countries. Methods: This study examined IQVIA-MIDAS sales ...
The world’s largest corporate holder of Bitcoin (BTC) says it plans to launch a new initial public offering (IPO) of a euro-denominated perpetual preferred stock. Strategy (MSTR) says it plans to ...
Strategy announced plans to sell 3.5 million shares of its new 10.00% Series A Perpetual Stream Preferred Stock (STRE). The issue will be registered under the U.S. Securities Act of 1933 and offered ...
Less than a week after Strategy (MSTR) reported Q3 earnings and hinted at launching an international perpetual preferred stock, the company has brought Stream (STRE) to market, a euro-denominated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results